Metraipolis › archive › dc_9362e564fbac

NQO1/p65/CXCL12 Axis-Recruited Tregs Mediate Resistance to Anti-PD-1 Plus Lenvatinib Therapy in PIVKA-II-Positive Hepatocellular Carcinoma — Europe PMC PMID:41028931

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41028931
DOI
10.1002/advs.202511152
License (as archived)
solo-consultazione
Archived
2026-11-09T16:50:10.753Z
SHA-256 of the archived text
f02b38ce09239885c8d92da9db8365664d8e035ac25e540ab956bcd96fa05a25
Stable URL of this page
https://metraipolis.com/documento/dc_9362e564fbac

How to cite

NQO1/p65/CXCL12 Axis-Recruited Tregs Mediate Resistance to Anti-PD-1 Plus Lenvatinib Therapy in PIVKA-II-Positive Hepatocellular Carcinoma — Europe PMC PMID:41028931 — Europe PMC (en), https://europepmc.org/article/MED/41028931 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9362e564fbac (Metraipolis archive dc_9362e564fbac, sha256 f02b38ce09239885c8d92da9db8365664d8e035ac25e540ab956bcd96fa05a25)
BibTeX
@misc{dc9362e564fbac,
  title = {NQO1/p65/CXCL12 Axis-Recruited Tregs Mediate Resistance to Anti-PD-1 Plus Lenvatinib Therapy in PIVKA-II-Positive Hepatocellular Carcinoma — Europe PMC PMID:41028931},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41028931},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9362e564fbac; sha256 f02b38ce09239885c8d92da9db8365664d8e035ac25e540ab956bcd96fa05a25},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41028931. Agents can read the archived copy with the MCP tool read_document.